FDA
approval
· 2023-04-26
FDA Approved: TRIKAFTA — Original Application (Vertex Pharmaceuticals Incorporated)
Summary
The FDA approved TRIKAFTA (elexacaftor/tezacaftor/ivacaftor) as an original application for cystic fibrosis, representing a pivotal triple-combination therapy f…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)